|
|
||||||||
Gastroenterology Research Unit and Section of Nuclear Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Correspondence: For correspondence or reprints contact: Michael Camilleri, MD, Mayo Clinic, Gastroenterology Unit, Alfred 2-435, 200 First St. SW., Rochester, MN 55905.
ABSTRACT
Scintigraphic measurementof colonic transit is currently performed by delivering 111In ion exchange resin pellets to the colon in a methacrylate-coated capsule. However, use of this method is constrained by the need for an investigational drug permit. We have demonstrated previously optimal adsorption in vitro of commonly used radioisotopes (e.g., 99mTc or 111In) to activated charcoal in milieus that mimicked gastric and small intestinal content The aim of this study was to compare the transit profiles of radioactive activated charcoal and resin pellets delivered to the colon in the same methacrylate-coated capsule. Methods: In 10 healthy voluntears, we compared the colonic transit profiles over 32 hr of simultaneously administered resin pellets labeled with 111In and activated charcoal mixed with 99mTc-diethylenetriaminepentaacetic acid. Transit was summarized as the geometric center (weighted average of counts) in the colon at each scanning period. Results: Colonic transit profiles were virtually identical with the two markers, with less than 0.1 geometric center unit differences in the transit profiles over the 32-hr periods. Conclusion: Activated charcoal is a suitable alternative to resin pellets when delivered in a methacrylatecoated, delayed-release capsule to the colon for measurement of transit by scintigraphy.
Key Words: colonic transit charcoal scintigraphy
This article has been cited by other articles:
![]() |
G. Mariani, E. K.J. Pauwels, A. AlSharif, S. Marchi, G. Boni, M. Barreca, M. Bellini, M. Grosso, N. de Bortoli, G. Mumolo, et al. Radionuclide Evaluation of the Lower Gastrointestinal Tract J. Nucl. Med., May 1, 2008; 49(5): 776 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. M. Grudell, M. Camilleri, K. L. Jensen, A. E. Foxx-Orenstein, D. D. Burton, M. D. Ryks, K. L. Baxter, D. S. Cox, G. E. Dukes, D. L. Kelleher, et al. Dose-response effect of a {beta}3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1114 - G1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Camilleri, P. Carlson, S. McKinzie, A. Grudell, I. Busciglio, D. Burton, K. Baxter, M. Ryks, and A. R. Zinsmeister Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G13 - G19. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Bharucha, A. J. Croak, J. B. Gebhart, L. J. Berglund, B. M. Seide, A. R. Zinsmeister, and K.-N. An Comparison of rectoanal axial forces in health and functional defecatory disorders Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1164 - G1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Camilleri, A. E. Bharucha, R. Ueno, D. Burton, G. M. Thomforde, K. Baxter, S. McKinzie, and A. R. Zinsmeister Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers Am J Physiol Gastrointest Liver Physiol, May 1, 2006; 290(5): G942 - G947. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Delgado-Aros, H. J. Chial, M. Camilleri, L. A. Szarka, F. T. Weber, J. Jacob, I. Ferber, S. McKinzie, D. D. Burton, and A. R. Zinsmeister Effects of a kappa -opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G558 - G566. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Viramontes, A. Malcolm, M. Camilleri, L. A. Szarka, S. McKinzie, D. D. Burton, and A. R. Zinsmeister Effects of an alpha 2-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1468 - G1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-M. Law, A. E. Bharucha, A. S. Undale, and A. R. Zinsmeister Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1228 - G1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A E Bharucha, M Camilleri, S Haydock, I Ferber, D Burton, S Cooper, D Tompson, K Fitzpatrick, R Higgins, and A R Zinsmeister Effects of a serotonin 5-HT4 receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans Gut, November 1, 2000; 47(5): 667 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Samsom, L. A. Szarka, M. Camilleri, A. Vella, A. R. Zinsmeister, and R. A. Rizza Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G946 - G951. [Abstract] [Full Text] [PDF] |
||||
![]() |
E P Bouras, M Camilleri, D D Burton, and S McKinzie Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans Gut, May 1, 1999; 44(5): 682 - 686. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |